234 related articles for article (PubMed ID: 7831315)
1. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.
Schwarz JK; Bassing CH; Kovesdi I; Datto MB; Blazing M; George S; Wang XF; Nevins JR
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):483-7. PubMed ID: 7831315
[TBL] [Abstract][Full Text] [Related]
2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
4. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Johnson DG; Ohtani K; Nevins JR
Genes Dev; 1994 Jul; 8(13):1514-25. PubMed ID: 7958836
[TBL] [Abstract][Full Text] [Related]
5. The cellular effects of E2F overexpression.
Adams PD; Kaelin WG
Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani K; DeGregori J; Nevins JR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
[TBL] [Abstract][Full Text] [Related]
7. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
8. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
9. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
11. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
[TBL] [Abstract][Full Text] [Related]
12. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
14. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.
DeGregori J; Kowalik T; Nevins JR
Mol Cell Biol; 1995 Aug; 15(8):4215-24. PubMed ID: 7623816
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
Wang S; Nath N; Minden A; Chellappan S
EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
[TBL] [Abstract][Full Text] [Related]
17. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
19. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
20. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
